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Background: Vitamin D, which influences cellular proliferation and breast tissue characteristics, has been inversely
correlated with breast cancer risk. Dietary vitamin D intake has been associated with lower mammographic density
(MD), a strong intermediate marker of breast cancer risk.
Findings: We examined the relationship between MD and serum 25-hydroxyvitamin D [25(OH)D], an integrated
measure of vitamin D status from dietary sources and sunlight exposure, in a multi-ethnic cohort of women
undergoing screening mammography. We recruited women age 40–60 years without a history of breast cancer
at the time of their routine screening mammogram, and conducted in-person interviews and collected blood
specimens. We enrolled 195 women from 2007–2008, 120 gave blood, and 114 were evaluable, including 25%
white, 41% African American, 18% African Caribbean, and 16% Hispanic. We digitized mammograms and calculated
percent density, dense area, and non-dense area on cranial-caudal images. We measured serum 25(OH)D in batched,
archived specimens. Median serum 25(OH)D was 22 ng/ml (range, 8–66 ng/ml). In univariable analysis, higher serum 25
(OH)D was associated with white race, higher educational level, ever breast feeding, and blood draw during the
summer. After adjusting for body mass index and other confounders, we found no association between serum
25(OH)D and different measures of MD. However, when stratified by season, 25(OH)D was inversely associated
with dense area during July-December (p = 0.034).
Conclusions: Overall, our findings suggest that circulating vitamin D, a potentially modifiable breast cancer risk
factor, is not associated with MD; the seasonal effects we observed need to be replicated in larger cohorts.
Keywords: Vitamin D, 25-hydroxyvitamin D, Breast cancer, Mammographic densityIntroduction
Vitamin D has a number of anti-tumor properties, in-
cluding inhibition of cell proliferation and induction of
apoptosis and differentiation [1]. In observational studies
of breast cancer and vitamin D status, women in the
highest quantile of circulating vitamin D had a 45% re-
duced risk of breast cancer compared to those in the
lowest quantile [2].
However, the effect of vitamin D on mammographic
density (MD), one of the strongest predictors of breast
cancer, remains unclear. MD refers to the relative* Correspondence: kd59@columbia.edu
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unless otherwise stated.proportions of radiolucent fat and radiodense fibro-
glandular tissue within the breast on mammography
[3]. Serum 25-hydroxyvitamin D [25(OH)D] provides
an integrated measure of vitamin D status from diet,
supplements, and sunlight exposure and is considered
the best indicator of vitamin D body stores [4]. We ex-
amined the association between MD and serum 25
(OH)D in a cross-sectional study of racially/ethnically
diverse women undergoing screening mammography.
Methods
We enrolled 195 women age 40–60 years without a per-
sonal history of breast cancer to the New York City
Multiethnic Breast Cancer Project from January 2007 to
April 2008. Participants were enrolled at their routine
screening mammography visits at Long Island College
Hospital (LICH) in Brooklyn, New York, as previouslytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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views providing information on demographics and breast
cancer risk factors and consented to allow study investi-
gators access to their mammograms; 120 (62%) partici-
pants provided a blood sample and 114 were evaluable
for serum 25(OH)D measurements [5]. The study proto-
col was approved by the Institutional Review Boards ofTable 1 Baseline characteristics of New York city multiethnic
above and below the median; 2007-2008
Characteristic Total (N = 11
Mean age at interview, years (SD) 50.0 (5.8)
Race/ethnicity, N (%)
White 28 (25)
African American 47 (41)
African Caribbean 21 (18)
Hispanic/Other 18 (16)
Menopausal status, N (%)
Pre/perimenopausal 73 (64)
Postmenopausal 41 (36)
Highest level of education, N (%)
≤High school 34 (30)
Some college/associate degree 35 (31)
≥College degree 45 (39)
Mean body mass index, kg/m2 (SD) 29.2 (6.3)
First-degree family history of breast cancer, N (%)
Yes 17 (15)
No 96 (85)
Mean age at menarche, years (SD) 12.5 (1.8)
Mean parity, N (SD) 1.6 (1.4)
Mean age at first live birth, years (SD) 22.6 (6.8)
Ever breast fed, N (%)
Yes 46 (40)
No 68 (60)
Ever hormonal birth control use, N (%)
Yes 78 (68)
No 36 (32)





Mean percent density, % (SD) 12.9 (11.4)
Mean dense area, cm2 (SD) 17.4 (14.7)
Mean non-dense area, cm2 (SD) 148 (82.3)
aMedian 25(OH)D of 22 ng/ml.
bP-value based upon 2-sample t-tests for continuous variables and chi-square testsLICH, Long Island University and Columbia University
Medical Center (CUMC).
We measured serum 25(OH)D in batched, archived
specimens by Diasorin radioimmuoassay (Stillwater, MN).
Interassay precision for quality controls were 14% and
18% at 15 ng/ml and 48 ng/ml, respectively. We evaluated
digitized mammograms for dense area (cm2), non-densebreast cancer project (N = 114) by serum 25(OH)D levels
4) Serum 25(OH)D P-valueb
≤ Mediana > Mediana
49.4 (5.9) 50.7 (5.6) 0.233
8 (14) 20 (36) 0.008
32 (54) 15 (27)
9 (15) 12 (22)
10 (17) 8 (15)
41 (69) 32 (58) 0.209
18 (31) 23 (42)
22 (37) 12 (22) 0.045
20 (34) 15 (27)
17 (29) 28 (51)
30.3 (6.1) 28.1 (6.3) 0.055
10 (17) 7 (13) 0.554
49 (83) 47 (87)
12.3 (1.8) 12.6 (1.8) 0.366
1.5 (1.5) 1.7 (1.3) 0.534
21.7 (6.9) 23.5 (6.7) 0.248
17 (29) 29 (53) 0.009
42 (71) 26 (47)
43 (73) 35 (64) 0.289
16 (27) 20 (36)
34 (58) 28 (51) 0.017
19 (32) 10 (18)
6 (10) 13 (24)
0 (0) 4 (7)
13 (11.1) 12.7 (11.8) 0.875
19.7 (16.1) 14.9 (12.8) 0.086
158 (78.2) 137 (85.9) 0.185
for categorical variables.
Table 2 Multivariable linear regression estimates of
percent density (%), dense area (cm2), and non-dense
area (cm2), New York city multiethnic breast cancer
project, 2007-2008
Characteristic β coefficient 95% CI P-value
Percent Density (%)
Serum 25(OH)D (ng/ml) −0.013 −0.188 0.161 0.880
Age at mammogram (years) −0.576 −0.921 −0.230 0.001
Race/ethnicity
White Reference
African American 1.762 −3.831 7.355 0.533
African Caribbean 3.169 −3.274 9.613 0.332
Hispanic/Other −2.094 −8.860 4.672 0.541
Education
≤High school −2.017 −7.157 3.123 0.438
Some college/associate
degree




Body mass index (kg/m2) −0.503 −0.873 −0.133 0.008
Ever breast feeding
Yes 1.038 −3.015 5.091 0.612
No Reference
Season of blood draw
January-March Reference
April-June 0.761 −3.983 5.505 0.751
July-September −5.398 −11.259 0.462 0.071
October-December −5.464 −16.201 5.274 0.315
Dense Area (cm2)
Serum 25(OH)D (ng/ml) −0.094 −0.332 0.143 0.432
Age at mammogram (years) −0.624 −1.101 −0.146 0.011
Race/ethnicity
White Reference
African American 5.421 −2.299 13.142 0.167
African Caribbean 5.838 −2.899 14.576 0.188
Hispanic/Other −2.643 −11.985 6.700 0.576
Education
≤High school −0.243 −7.254 6.767 0.945
Some college/associate
degree




Body mass index (kg/m2) −0.170 −0.680 0.341 0.511
Season of blood draw
January-March Reference
April-June 3.430 −3.128 9.988 0.302
July-September −6.680 −14.763 1.403 0.104
October-December −6.718 −21.564 8.128 0.371
Table 2 Multivariable linear regression estimates of
percent density (%), dense area (cm2), and non-dense
area (cm2), New York city multiethnic breast cancer
project, 2007-2008 (Continued)
Non-Dense Area (cm2)
Serum 25(OH)D (ng/ml) 0.209 −0.823 1.242 0.688
Age at mammogram (years) 3.346 1.302 5.390 0.002
Race/ethnicity
White Reference
African American 12.640 −20.455 45.735 0.533
African Caribbean 6.186 −31.943 44.315 0.748
Hispanic/Other −2.090 −42.125 37.946 0.918
Education
≤High school 22.854 −7.560 53.269 0.139
Some college/associate
degree




Body mass index (kg/m2) 7.142 4.952 9.331 <.001
Ever breast feeding
Yes −17.582 −41.566 6.402 0.149
No Reference
Season of blood draw
January-March Reference
April-June −0.074 −28.145 27.997 0.996
July-September 23.080 −11.597 57.757 0.190
October-December 8.404 −55.132 71.940 0.794
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total breast area) on cranial-caudal images using Cumulus
software, as previously described [5]. The Pearson correl-
ation coefficients for repeated readings of a randomly se-
lected 10% subset of mammograms were 0.99 and 0.9 for
breast area and dense area, respectively.
We performed 2-sample t-tests and chi-square tests to de-
termine whether the distribution of selected breast cancer
risk factors differed by serum 25(OH)D. We used linear re-
gression models to investigate the association of MD with
serum 25(OH)D. We assessed for confounding by using the
change in estimate criteria of 10% or more for estimates of
the association between serum 25(OH)D and MD after add-
ing each known potential confounding variable to the bivari-
able model. The multivariable models included age, race/
ethnicity, education, body mass index (BMI, kg/m2), ever
breast-feeding, and season of blood draw (January-March,
April-June, July-September, October-December). We also
conducted stratified analyses based upon menopausal status,
BMI (≤30 vs. >30 kg/m2), and season (January-June vs.
July-December). All statistical analyses were conducted
using SAS version 9.2 (Cary, NC).
Table 3 Multivariable linear regression estimates of
dense area (cm2) stratified by season of blood draw
(January-June, July-December), New York city multiethnic
breast cancer project, 2007-2008
Characteristic β coefficient 95% CI P-value
January-June (N = 91)
Serum 25(OH)D (ng/ml) −0.046 −0.338 0.246 0.757
Age at mammogram (years) −0.813 −1.421 −0.205 0.009
Race/ethnicity
White Reference
African American 6.014 −3.463 15.491 0.210
African Caribbean 8.406 −2.912 19.724 0.143
Hispanic/Other −2.480 −13.841 8.882 0.665
Education
≤High school −1.405 −9.837 7.027 0.741
Some college/associate
degree




Body mass index (kg/m2) 0.056 −0.540 0.653 0.851
July-December (N = 23)
Serum 25(OH)D (ng/ml) −0.254 −0.487 −0.022 0.034
Age at mammogram (years) −0.272 −0.711 0.167 0.204
Race/ethnicity
White Reference
African American 5.525 −1.281 12.332 0.103
African Caribbean 1.711 −5.984 9.406 0.639
Hispanic/Other 3.002 −8.678 14.682 0.588
Education
≤High school 0.492 −6.070 7.053 0.874
Some college/associate
degree




Body mass index (kg/m2) −0.892 −1.323 −0.462 0.001
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The median serum 25(OH)D for the entire sample was
22 ng/ml (range 8–66 ng/ml). Forty-seven (41%) women
had serum 25(OH)D levels in the deficient range (<20
ng/ml), 32 (28%) in the insufficient range (20–29 ng/ml),
and 35 (31%) in the sufficient range (≥30 ng/ml). Base-
line characteristics according to groups above and below
the median serum 25(OH)D are shown in Table 1. In
univariable analysis, having a serum 25(OH)D above the
median was associated with white race, higher educational
level, ever breast feeding, blood draw during the summer,
and a trend toward lower dense area (p = 0.086).
After adjusting for age, race/ethnicity, education, BMI,
ever breast feeding, and season of blood draw, we found
no association between 25(OH)D and the different mea-
sures of MD (Table 2), even when stratified by meno-
pausal status and BMI. We did, however, observe a
trend toward lower percent density during the late sum-
mer (July-September), when the highest levels of serum
25(OH)D were observed. Stratified analysis by season
(Table 3) revealed that serum 25(OH)D was inversely asso-
ciated with dense area in multivariable analysis (p = 0.034)
during the months of July-December.
Discussion
Overall, we observed a non-significant trend toward lower
dense area in participants with higher serum 25(OH)D,
which was no longer significant after adjustment for BMI
and other confounders. However, during the months of
July-December, we observed a significant inverse associ-
ation between serum 25(OH)D and dense area, which
may be a better a measure of MD in obese women.
A recent systematic review of fourteen studies examin-
ing the association between vitamin D and MD [6] in-
cluded twelve cross-sectional studies [7-18] and two
prospective studies [19,20]. Nine studies assessed vita-
min D status by dietary and supplement intake [12-20]
and five studies by circulating 25(OH)D levels [7-11].
Only four studies considered dense area as a measure of
MD [7,10,11,15] and five studies included populations
which were diverse by race and ethnicity [10,11,15-17].
Five out of nine studies which assessed dietary intake
of vitamin D reported a significant inverse association
between vitamin D and MD [8,13-15,18]. When strati-
fied by menopausal status, much of the association was
limited to premenopausal women [13-15]. In a sub-study
of the Women’s Health Initiative (WHI), no association
was observed between vitamin D or calcium intake and
MD among postmenopausal women, however, supple-
mental vitamin D use was associated with lower density in
younger women [17]. Of note, we did not observe an asso-
ciation between 25(OH)D and MD when stratified by
menopausal status, however, this subgroup analysis was
limited by our relatively small sample size.More recent studies that assessed serum 25(OH)D levels
in relation to MD have reported null findings [7-11]. One
study found that women in the highest quartile of serum
25(OH)D had the lowest density measurements, although
no significant relationship between serum 25(OH)D levels
and MD was reported [7]. No association was found be-
tween circulating levels of 25(OH)D and MD among
postmenopausal women in the Nurses’ Health Study.
However, women in the highest tertile of MD and low-
est tertile of plasma 25(OH)D had a 4-fold increased
risk of breast cancer compared to women with the
lowest MD and highest plasma 25(OH)D [9].
A limitation of all of these studies was that the blood
collections for serum 25(OH)D and mammograms were
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vals varying from 1–8 years), unlike our study in which
the blood sample and mammogram were collected on
the same day. Although most studies adjusted for time
between blood draws and mammograms, this may not
account for the seasonal variation in vitamin D status.
Brisson et al. reported synchronized seasonal variations
of MD and 25(OH)D blood levels, demonstrating that
the lowest breast density was observed in early December,
approximately 4 months after peak serum 25(OH)D [8].
During July-December when serum 25(OH)D are at their
highest levels, we observed an inverse association between
vitamin D status and dense area.
We measured serum 25(OH)D in batched archived
blood samples using the well-validated Diasorin radio-
immunoassay. Prior research has demonstrated that cir-
culating 25(OH)D is very stable in serum with long-term
storage [21]. There is increasing use of LS-MS technol-
ogy, which allows for quantification of 25(OH)D2 and
25(OH)D3 separately. However, the clinical utility of
separately measuring D2 and D3, as opposed to total
25(OH)D, is uncertain [21].
Percent density is a measurement of the dense breast
tissue relative to non-dense, primarily fat tissue, and as
such percent density partly accounts for differences in
breast size. However, it may underestimate MD in obese
women with large amounts of fat. We also assessed
dense area and non-dense area, which were only evalu-
ated in four other studies as measures of MD [7,10,11,15].
Given that the mean BMI of our study population was
relatively high at 29.2 kg/m2, dense area may be a more
accurate way of assessing breast cancer risk in these
women. Obesity has been positively associated with post-
menopausal breast cancer risk [22] and is also inversely
related to vitamin D status. People who are overweight
and obese have a higher prevalence of vitamin D defi-
ciency compared to lean individuals due to decreased bio-
availability of fat-soluble vitamin D and sequestration in
adipose tissue [23].
The main limitation of our study is the relatively small
sample size. Strengths of our study include the large Af-
rican American sample, comprehensive examination of
risk factors, adjustment for season, use of an objective
measure of vitamin D exposure, collection of blood and
mammograms at the same time point, and assessment of
three different measures of MD. In particular, dense area
is less studied and may be more relevant in a study
population with a high prevalence of obesity.
In conclusion, serum 25(OH)D status, a potentially
modifiable breast cancer risk factor, was not associated
with MD in this cross-sectional study. However, we did
observe an inverse association with dense area based
upon season, which needs to be replicated in larger stud-
ies. Since a one-time measurement of serum 25(OH)Dmay not reflect lifetime exposure to vitamin D, future
prospective studies should examine changes in vitamin
D exposure over time in relation to MD and breast can-
cer risk, since few longitudinal studies to date have doc-
umented changes in vitamin D status with changes in
MD over time [24].
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